University Of Massachusetts Medical School

University of Massachusetts Medical School (UMMS), operating as a division of University of Massachusetts and doing business as Umms, is a state government entity and 1862 Land Grant institution that delivers clinical and research services to the federal government as both a prime contractor and recipient, with headquarters in Worcester, Massachusetts. UMMS operates across 93% prime contracts and 7% subcontracts, competing in full-and-open federal procurement without SBA set-asides; the institution's federal footprint spans 118 customer agencies with primary concentration in civilian correctional healthcare and biomedical research funding.

UMMS's federal contract portfolio centers on comprehensive medical services delivery to Bureau of Prisons facilities. The institution's largest customer concentration is the Federal Correctional Complex Butner (375 awards, $875.9 million combined potential value) and Federal Medical Center Devens (729 awards, $422.6 million), accounting for 68% of combined potential value across all awards. Recent work includes monthly firm fixed-price delivery orders for comprehensive inpatient and outpatient medical services at Federal Correctional Complex Butner (ranging $894,000–$3.5 million per monthly order), outside hospital medical services for inmate populations at FMC Devens (orders of $350,000–$2.5 million), and specialized surgical procedures including kidney and heart transplants ($226,000–$974,000 per transplant). UMMS also holds a single-award Indefinite Delivery Contract with Veterans Integrated Service Network 1 (ceiling $1.050 million, ultimate completion July 31, 2027) for research support services, with three task orders issued in FY2025–FY2026 ranging $122,000–$150,000.

The institution's largest parent vehicles are blanket purchase agreements with the Federal Medical Center Devens and Federal Correctional Complex Butner. BPA DJBDEV2050705007 carries 842 task orders valued at $489.1 million combined potential value; IDC DJBP020500000016 supports 214 task orders worth $81 million; and IDC 15B20521D00000001 (underlying contract for FMC Devens outpatient institution and transplant services) anchors 159 task orders valued at $68.4 million. These vehicles represent routine, recurring medical service delivery rather than competitive procurements.

UMMS's federal grant footprint is substantial and research-intensive. Recent grants across fiscal years 2025–2026 total over $100 million in project awards from National Institutes of Health institutes (NIAID, NHLBI, NIDDK, NIA, NICHD, NIMH, NINDS, NIGMS), the Defense Health Agency, the National Cancer Institute, the CDC, NSF, and NIDA. Representative recent recipients include $7.34 million from the National Institute of Nursing Research for school-based health centers research on pediatric asthma (award April 16, 2026, completion March 31, 2030); $3.65 million from NIDA for a supporting treatment access and recovery re-entry study (September 1, 2025–May 31, 2030); $4.56 million from NIDA for Jail ECHO operations research (September 1, 2025–May 31, 2030); $5.955 million from NCATS for the University of Massachusetts Clinical and Translational Science program (UMCCTS cooperative agreement, March 1, 2026–January 31, 2033); and multiple $200,000–$900,000 project grants from NIA, NIAID, NHLBI, and NIGMS supporting basic biomedical research in immunology, cancer biology, neurodegenerative disease, and cardiovascular biology. UMMS acts as prime recipient on all identified grant awards; sub-recipient engagement includes partnerships with 40+ academic institutions and medical centers (Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Brown University, Duke University, Tufts University, University of Wisconsin, Cornell University, and others) contributing specialized research support, biostatistics, and translational services.

Activity has grown substantially: five-year award volume increased from 186 awards in 2022 to 301 in 2024, declining to 231 in 2025 and 114 through mid-2026 (reflecting partial-year reporting). SCI-reportable invoiced revenue from service contracts above the $150,000 threshold reached $76.3 million in FY2024 across 22.7 FTEs, up from $59.5 million in FY2022. Government-paid hourly rates on federal service contracts (prime records) range from $291/hr at the 10th percentile to $481/hr at the 90th percentile, with median around $417/hr, reflecting a mix of clinical, research, and administrative labor. Recompete exposure in the next twenty-four months includes 230 awards with combined potential value of $3.4 million, primarily monthly correctional healthcare purchase orders and research delivery orders with completion dates between July 2026 and July 2027.

UMMS operates as a single-awardee prime with minimal subcontractor engagement. Across SCI-reportable prime contracts, subcontractors perform 0% of total contractor hours; seven named subcontractors appear across the sub-award portfolio. Named sub-awardees on grant work include Joslin Diabetes Center, Baystate Medical Center, California Institute of Technology, Duke University, and multiple major research universities contributing discipline-specific expertise in metabolomics, clinical implementation, and advanced analytics. The institution's corporate structure identifies two named subsidiaries: Worcester City Campus Corporation and University of Massachusetts Medical School itself (both state government entities). UMMS remains parent-owned within the University of Massachusetts system.